To include your compound in the COVID-19 Resource Center, submit it here.

AMR102: Clinical trial ongoing

Amarin completed dosing in an open-label, U.S. clinical trial

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE